Ocular Therapeutix
OCUL
OCUL
148 hedge funds and large institutions have $1.13B invested in Ocular Therapeutix in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding
Funds holding: 118 → 148 (+30)
16.37% more ownership
Funds ownership: 67.17% → 83.54% (+16%)
79% less call options, than puts
Call options by funds: $2.95M | Put options by funds: $14.4M
Holders
148
Holding in Top 10
8
Calls
$2.95M
Puts
$14.4M
Top Buyers
| 1 | +$65.1M | |
| 2 | +$61M | |
| 3 | +$48.4M | |
| 4 |
VA
VR Adviser
New York
|
+$45.4M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$31.8M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$5.51M | |
| 3 | -$5.35M | |
| 4 |
BS
Banco Santander
Madrid,
Spain
|
-$3.02M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.1M |